Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Videos

Regulated gene expression systems.

¹ARIAD Gene Therapeutics Inc, 26 Landsdowne Street, Cambridge, MA 02139, USA.

|February 16, 2000

Summary

This summary is machine-generated.

Gene therapy aims to deliver therapeutic genes, but controlling their expression is crucial for clinical success. New drug-regulated gene therapy systems show promise, with clinical trials anticipated soon.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

A phase 2 trial of ponatinib in Philadelphia chromosome-positive leukemias.

The New England journal of medicine·2013

Same author

Evaluation of a rapamycin-regulated serotype 2 adeno-associated viral vector in macaque parotid glands.

Oral diseases·2010

Same author

Rapamycin control of transgene expression from a single AAV vector in mouse salivary glands.

Gene therapy·2005

Same author

Constitutive and regulated expression of processed insulin following in vivo hepatic gene transfer.

Gene therapy·2002

Same author

Intravenous safety and pharmacokinetics of a novel dimerizer drug, AP1903, in healthy volunteers.

Journal of clinical pharmacology·2001

Same author

A Fas-based suicide switch in human T cells for the treatment of graft-versus-host disease.

Blood·2001

Same journal

Improving the precision of AAV lung gene therapy for SP-B deficiency using computationally derived lung-specific promoters.

Gene therapy·2026

Same journal

Recent advancements in improving cross-species applicability of bioengineered AAV capsids.

Gene therapy·2026

Same journal

Assessment of F/HN-pseudotyped lentiviral vector following intravenous delivery to mice.

Gene therapy·2026

Same journal

Applications of genome editing technologies in the treatment of human diseases.

Gene therapy·2026

Same journal

High resolution ES-DMA quantifies AAV capsid DNA content by electrical mobility to mass correlation.

Gene therapy·2026

Same journal

AAV8-mediated mouse/human PROC expression rescues thrombophilia in hereditary protein C-deficient mice.

Gene therapy·2026

See all related articles

Area of Science:

Molecular Biology
Gene Therapy
Pharmacology

Background:

Gene therapy research has primarily focused on efficient gene delivery to target cells.
Controlling gene expression post-delivery is critical for therapeutic efficacy and safety.
Drug-inducible systems offer a promising avenue for precise gene regulation.

Purpose of the Study:

To highlight the importance of gene expression regulation in gene therapy.
To review progress in developing drug-regulated gene expression systems.
To forecast the clinical translation of these advanced gene therapy approaches.

Main Methods:

Review of current gene therapy delivery strategies.
Analysis of advancements in designing inducible gene expression systems.

Related Experiment Videos

Assessment of orally active drug-controlled gene expression technologies.

Main Results:

Significant progress has been achieved in developing systems for drug-controlled gene expression.
Orally active drugs have been successfully employed to regulate gene expression.
These advancements pave the way for novel therapeutic applications.

Conclusions:

Gene expression regulation is essential for the clinical viability of gene therapy.
Drug-regulated gene therapy represents a significant step towards mainstream clinical application.
The first clinical trials of drug-regulated gene therapies are expected in the near future.